NEW YORK (Reuters) -Purdue Pharma ... The settlement was announced nearly seven months after the U.S. Supreme Court upended ...
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...
Purdue Pharma and the members ... for bankruptcy protections, the Sacklers themselves did not. New York Attorney General Letitia James (D) said the overall settlement was worth up to $7.4 billion ...
The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...
Purdue Pharma and the Sackler family that own the company have agreed to a $7.4 billion settlement in principle with 15 ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Purdue Pharma and its Sackler family owners ... attempt to resolve the lawsuits in a bankruptcy settlement that would have granted the Sacklers sweeping civil immunity from opioid lawsuits in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results